Prevention of Intellectual Impairment with Neonatal Hypothyroidism Screening
Mary Perry Alexander
Takara Stanley
Effects of Neonatal Screening for Hypothyroidism: Prevention of Mental Retardation by Treatment Before Clinical Manifestations
New England Congenital Hypothyroidism Collaborative. Lancet. 1981;2(8255):1095–1098
Background
Untreated congenital hypothyroidism (CH) is known to cause impaired intellectual development and neuropsychological problems. The advent of neonatal screening for hypothyroidism in the 1970s allowed infants with low thyroxine (T4) and elevated thyroid-stimulating hormone (TSH) to be identified and treated before any clinical evidence of hypothyroidism was apparent. This study presented the intelligence quotient (IQ) outcomes for a cohort of infants found to be hypothyroid on newborn screening at a time when newborn screening programs were in their infancy.
Objectives
To determine the impact of early thyroid hormone replacement on the intellectual development of infants identified as hypothyroid on routine newborn screening.
Methods
Retrospective, case-control study in 5 US states from 1976 to 1978.
Patients
77 infants with hypothyroidism (T4 level <6 mcg/dL and TSH concentration >40 μU/dL on 2 blood tests, or between 20 to 40 μU/dL on 3 to 4 tests) diagnosed by routine screening of over 300,000 infants, and 4 infants diagnosed clinically at birth. Control group was 18 normal siblings and 39 euthyroid infants with low T4 but normal TSH.